+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06637137

Optimizing Iron Levels Before Cardiac Surgery to Reduce Blood Transfusions The ICARUS-2 Observational Study

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2026-09-10

464

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients undergoing elective cardiac surgery to improve management of iron levels and reduce the need for blood transfusions during and after surgery. This observational study focuses on correcting iron deficiency before surgery as part of patient blood management programs, aiming to enhance recovery and potentially reduce hospital stays and costs. Patients found to have low iron levels receive intravenous iron treatment at least two weeks before their scheduled surgery, along with vitamin B12 injections and oral folic acid supplements. The study compares current patients receiving early iron correction with previous patient groups who either received late or no iron supplementation. Throughout the study, participants have their blood tests monitored before and after surgery. Researchers track outcomes such as the percentage needing red blood cell transfusions within seven days after surgery, hemoglobin levels, use of blood products, length of intensive care and hospital stays, treatment costs, and mortality. The study continues until 2027, collecting data over an average of two years post-surgery.

CONDITIONS

Brief Title

Patient Blood Management in Patients Scheduled for Cardiac Surgery

Research Team

F

filippo Corsi, MD

L

Luciana Teofili, PhD, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here